Erratum: Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation (Cancer Chemother Pharmacol (2013) 71 (43-51))

Yoon Koo Kang, Byung Woog Kang, Seock Ah Im, Jae Lyun Lee, Sook Ryun Park, Won Ki Kang, Heung Moon Chang, Tae Won Kim, Do Youn Oh, Kyung Hae Jung, Min Hee Ryu

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)551-552
Number of pages2
JournalCancer Chemotherapy and Pharmacology
Volume71
Issue number2
DOIs
StatePublished - Feb 2013

Cite this